| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/08/2010 | CN101822843A Optimization of high-pathogenicity avian influenza virus H5N1-HA gene and recombinant adenovirus vaccine thereof |
| 09/08/2010 | CN101822842A Reformation of high-pathogenicity avian influenza virus H5N1-HA gene and recombinant adeno-associated virus vaccine thereof |
| 09/08/2010 | CN101822831A Application of transfer stimulating factor as new tumor blood vessel drone in antitumor medicine screening |
| 09/08/2010 | CN101822830A Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 09/08/2010 | CN101822829A Recombinant BCG vaccine for tuberculosis prevention |
| 09/08/2010 | CN101475641B Adenovirus vector avian influenza recombinant vaccine |
| 09/08/2010 | CN101376878B Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby |
| 09/08/2010 | CN101311189B Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof |
| 09/08/2010 | CN101168741B Lactococcus lactis food-sate secretion expression carrier and its preparing method and application |
| 09/07/2010 | US7790876 using a replication composition in the form of a tablet, and a detection kit to perform of RT-PCR; highly sensitive assay for that broadly detects most strains of the virus, is rapid, accurate and easily performed |
| 09/07/2010 | US7790871 Anti-TNFα antibodies and methods of use |
| 09/07/2010 | US7790864 Antibody to BACE455, an alternative splice variant of the human beta-secretase |
| 09/07/2010 | US7790863 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 09/07/2010 | US7790860 Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids |
| 09/07/2010 | US7790859 Interferon specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 09/07/2010 | US7790858 Immunoadhesin comprising increased neonatal Fc receptor specificity for use in treatment and prevention of cell proliferative disorders |
| 09/07/2010 | US7790855 Used to diagnose and treat various diseases, including human cancers associated with expression and/or over-expression of KID3 |
| 09/07/2010 | US7790854 antibody zeta -C2 raised against the sequence set forth in SEQ ID NO:2, which specifically binds to the atypical isoform protein kinase M zeta (PKM zeta ); Alzheimer's disease (AD) and neuroblastoma; using aPKC in diagnosis, drug screening and gene therapy |
| 09/07/2010 | US7790853 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 09/07/2010 | US7790851 heterodimeric receptor complex comprising an isolated soluble cytokine receptor and a soluble zcytor11 polypeptide; for use in treatment of cell proliferative, inflammatory and immune disorders |
| 09/07/2010 | US7790843 Cypin polypeptide and fragments thereof |
| 09/07/2010 | US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment |
| 09/07/2010 | US7790696 Cationic liposomes containing immune response generating moieties |
| 09/07/2010 | US7790687 Treatment for neurodegeneration |
| 09/07/2010 | US7790672 Method of using lectins for prevention and treatment of oral and alimentary tract disorders |
| 09/07/2010 | US7790473 reacting a glycoside with an alkylthio acid to produce a thioester, debenzylidenating the thioester and hydrolyzing the thioester to produce a biofunctional group-thiol (Thomsen-Friedenreich-thiol ), refluxing product thiol with cadmium perchlorate, hydrogen sodium telluride and mercaptoacetic acid |
| 09/07/2010 | US7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor |
| 09/07/2010 | US7790434 Methods and compositions for expressing negative-sense viral RNA in canine cells |
| 09/07/2010 | US7790415 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents |
| 09/07/2010 | US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample |
| 09/07/2010 | US7790366 NANBV diagnostics and vaccines |
| 09/07/2010 | US7790362 Prostaglandin E1 as platelet inhibitor; signal transduction; solid phase synthesis; kits |
| 09/07/2010 | US7790188 Antifungal protein and usage thereof |
| 09/07/2010 | US7790187 Recombinant granule antigen protein (GRA6) for use in diagnosis, prevention and treatment of parasitic infection |
| 09/07/2010 | US7790186 synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax; malaria vaccine |
| 09/07/2010 | US7790185 Bacterial mutant for generating bacterial toxins for use in developing vaccine against infections; cultivating Bordetella pertussis bacteria that lack cysteine desulfinase activity by knocking out Bordetella pertussis cysteine desulfinase gene, whereby an enhanced amount of PT is produced |
| 09/07/2010 | US7790184 Using reporter gene expression profiles as tools to monitor efficacy of protein inhibitors |
| 09/07/2010 | US7790183 Precoated catheters for insertion into mammals ; urinary track infections |
| 09/07/2010 | US7790182 Protein vaccines against poxviruses |
| 09/07/2010 | US7790181 Vaccine preparations comprise full-length cDNA copies of the EEE genome which has been altered such that the RNA produced from the cDNA, and the virus produced there from is attenuated and useful as a live vaccine for human and veterinary use |
| 09/07/2010 | US7790180 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 09/07/2010 | US7790179 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 09/07/2010 | US7790178 vaccine for canine herpesvirus (CHV), canine rotavirus (CRV), and Minute virus of canine (MVC) or other canine parvovirus delivered to pups of a whelp through colostrums and providing sufficient antibody titer to impart protection |
| 09/07/2010 | US7790177 Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site |
| 09/07/2010 | US7790174 G-CSF polypeptides and uses thereof |
| 09/07/2010 | US7790173 Capsid proteins from RNA virus for use as immune modulators for treatment and prevention of viral infection |
| 09/07/2010 | US7790172 Methods for reducing nasopharyngeal colonization of non-typable Haemophilus influenzae with synthetic chimeric fimbrin peptides |
| 09/07/2010 | US7790171 Vircidal agent for treatment of multidrug-resistant human immunodeficiency viral infections |
| 09/07/2010 | US7790170 Transgenic plant comprising expression vector coding mannheimia modified toxin protein for use in preparing vaccine against respiratory infection in domestic animals; veterinary medicine |
| 09/07/2010 | US7790168 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 09/07/2010 | US7790166 Anti-CD40 antibodies capable of blocking B-cell activation |
| 09/07/2010 | US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 09/07/2010 | US7790164 Fab proteins; anticancer agents; immunoglobulins; gene expression inhibition; kits |
| 09/07/2010 | US7790163 Antibodies that bind both IL-17A and IL-17F and methods of using the same |
| 09/07/2010 | US7790161 GDF-9/BMP-15 modulators for the treatment of bone disorders |
| 09/07/2010 | US7790160 Using cytokine receptor (CD30) specific immunoglobulin to treat hodgkin's disease |
| 09/07/2010 | US7790159 inhibiting viral replication or infection using a composition with a virally infected cell which has an immunoconjugate comprising a first anti-viral agent operatively attached to an antibody, or antigen-binding fragment, that binds to an aminophospholipid; treatment of cancer and viral infections |
| 09/07/2010 | US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases |
| 09/07/2010 | US7790157 Methods of modulating CARK protein activity |
| 09/07/2010 | US7790154 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 09/07/2010 | US7790152 Monoclonal antibodies that preferntially bind to proteins having cytolysis and immunogenic activity |
| 09/07/2010 | US7790143 One or more antigen preparations from bacterial species having 16S rRNA sequence with at least 93% sequence identity to Candidatus Helicobacter suis; Helicobacter felis, salomonis, heilmannii, cynogastricus, baculiformis; whole-killed, attenuated, sonication lysis; in vivo propagation; oral, parenteral |
| 09/07/2010 | CA2608864C Recombinant mva virus, and the use thereof |
| 09/07/2010 | CA2596274C Recombinant mva virus, and the use thereof |
| 09/07/2010 | CA2531825C Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
| 09/07/2010 | CA2431188C Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens |
| 09/07/2010 | CA2406229C Anti-sepsis conjugate vaccine |
| 09/07/2010 | CA2277999C The 74 kilodalton outer membrane protein from moraxella catarrhalis |
| 09/05/2010 | CA2665771A1 Method and kit for effecting screening and immunogenic treatment using crt and/or erp57 translocation |
| 09/03/2010 | CA2695093A1 Method for diagnosing staphylococcal infections |
| 09/02/2010 | WO2010099547A1 Multiple antigen delivery system using hepatitis e virus-like particle |
| 09/02/2010 | WO2010099536A2 Engineered proteins with high affinity for dota chelates |
| 09/02/2010 | WO2010099472A2 Spanx-b polypeptides and their use |
| 09/02/2010 | WO2010099444A2 Modified live aeromonas hydrophila vaccine for aquatic animals |
| 09/02/2010 | WO2010099432A2 Recognition of cyp2e1 epitopes |
| 09/02/2010 | WO2010099322A1 Francisella tularensis variants: compositions and methods of use |
| 09/02/2010 | WO2010099186A1 Her2 antibody compositions |
| 09/02/2010 | WO2010099139A2 Combination anti-cancer therapy |
| 09/02/2010 | WO2010099019A1 Antibodies containing therapeutic tpo/epo mimetic peptides |
| 09/02/2010 | WO2010098863A1 Humanized platelet activating factor antibody design using anti-lipid antibody templates |
| 09/02/2010 | WO2010098682A1 Cell marker for melanocyte lineage and cancer cells and uses thereof |
| 09/02/2010 | WO2010098613A2 Tm7sf3 composition for diagnosing liver cancer, diagnostic kit containing anti-tm7sf3 antibodies, and pharmaceutical composition for preventing or treating liver cancer |
| 09/02/2010 | WO2010098503A1 Therapeutic agent for interstitial pneumonia |
| 09/02/2010 | WO2010098432A1 Immunogenic composition |
| 09/02/2010 | WO2010098429A1 Immunologic adjuvant composition and use thereof |
| 09/02/2010 | WO2010098166A1 Cell adhesion inhibitor and use thereof |
| 09/02/2010 | WO2010097977A1 Oral polyvalent vaccine against swine erysipelas/mycoplasmal pneumonia |
| 09/02/2010 | WO2010097825A1 Use of anti-90k monoclonal antibodies for the prevention and treatment of tumors and metastases thereof |
| 09/02/2010 | WO2010097709A2 Polypeptides for the prevention or treatment of malaria |
| 09/02/2010 | WO2010097625A1 Diagnostic method and kit |
| 09/02/2010 | WO2010097012A1 ANTI-CεmX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES |
| 09/02/2010 | WO2010096888A1 Vaccines containing attenuated strains, method for forming attenuated strains, vaccine vectors and use thereof for the treatment of salmonellosis |
| 09/02/2010 | WO2010075548A3 Immunoglobulin variants with altered binding to protein a |
| 09/02/2010 | WO2010066914A3 Remedies for pemphigus containing anti fas ligand antibodies |
| 09/02/2010 | WO2010063138A8 A monoclonal antibody specifically binding to vegf and the hybridoma secreting same and uses thereof |
| 09/02/2010 | WO2010060073A3 Method for treating parkinson' s disease using filamentous bacteriophage |
| 09/02/2010 | WO2010047509A9 Anti-dr5 antibody with improved affinity and stability, and composition for cancer prevention or treatment including same |
| 09/02/2010 | WO2010042760A3 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens |
| 09/02/2010 | WO2010040136A4 Selection of hiv vaccine antigens by use of intrapatient sequence variation to identify mutations in the hiv envelope glycoprotein that affect the binding of broadly neutralizing antibodies |
| 09/02/2010 | WO2010029546A3 Compositions and methods for treating s.pneumoniae infection |